$10.6M grant supports innovative autism project
McGill Translational Platform in Autism Research will help uncover the disorders’ neural foundations
A new project at The Neuro, McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC) has been awarded $10.6M in financial support as part of the Canada Foundation for Innovation’s (CFI) Innovation Fund.
Making AI a partner in neuroscientific discovery
New paper argues that Large Language Models can reveal breakthroughs humans alone cannotThe past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence data) has implications for people in many areas of human activity.
A neurological disease paradigm shift
Researchers propose a new model for classifying Parkinson’s
One of the things that makes developing effective treatments for Parkinson’s disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Parkinson’s is also currently made very late, after the disease may have been in the brain for a decade or more.
Open Science momentum grows stronger in Canada with a new commitment by its largest mental health teaching hospital
The Centre for Addiction and Mental Health (CAMH) joins the Tanenbaum Open Science Institute alliance in a partnership to open research practicesThe Centre for Addiction and Mental Health (CAMH), Canada’s largest mental health teaching hospital in the country is pleased to announce that it has entered into a partnership with the Tanenbaum Open Science Institute (TOSI) at McGill University
Assessing unintended consequences in AI-based neurosurgical training
Machine learning tutors affect learners in unforeseen ways, both positive and negativeVirtual reality simulators can help learners improve their technical skills faster and with no risk to patients. In the field of neurosurgery, they allow medical students to practice complex operations before using a scalpel on a real patient.
New insights into what makes multiple sclerosis worse and how to make it better
Scientists identify the first genetic marker for MS severity, opening the door to treatments for long-term disabilityA study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.
New digital consent platform streamlines consent process
Partnership with Novartis Pharmaceuticals Canada Inc. has created a faster, easier way for patients to contribute to research
$6M grant for new Open Science patient registry
Goal is to accelerate research and let patients know how their data is helping find treatmentsA $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.
Study finds obesity-related neurodegeneration mimics Alzheimer’s disease
Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groupsA new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.
Neuro director to co-chair new national clinical trial initiative
Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the countryToday the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr.
Frequent genetic cause of late-onset ataxia uncovered by a Quebec-led international collaboration
Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwideA new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.
A one-stop-shop for brain imaging
Software tool brings together multiple brain maps in one placeThe brain is a complex organ, and no one imaging mode can catch everything that’s going on inside it. Over the years, multiple “brain maps” have emerged, each focusing on different brain processes, from metabolism to cognitive function. While these maps are important, using them in isolation limits the discoveries researchers can make from them.
Quebec study on long COVID seeking participants
Purpose is to understand post-COVID symptom evolution and impact on patients’ livesAs of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what’s become known as long COVID, or post-COVID-19 syndrome.
Two Neuro faculty inducted into The Royal Society of Canada
Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life
Two faculty members at The Neuro (Montreal Neurological Institute-Hospital) have been inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.
